Oral Anticoagulation Therapy upon Discharge in Hospitalized Patients with Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVES: Availability of direct oral anticoagulants and CHA

METHODS: A retrospective cohort study was conducted using a de-identified data collection sheet for data extraction (demographics, admitting diagnosis, OACT prior to admission and at discharge, concomitant medications that could increase bleed risk and/or acid-suppressive therapies). CHA

RESULTS: Data from 180 patients were evaluated and of these 177 (98.3%) received OACT regardless of stroke risk upon discharge, as determined by CHA

CONCLUSIONS: Decision to add OACT is often guideline-driven, however, individualized circumstances in which clinicians and patients find themselves are also important considerations. Determination of ischemic stroke risk should be performed with CHA

Original languageAmerican English
Pages (from-to)22-29
Number of pages8
JournalHospital Practice
Volume46
Issue number1
DOIs
StatePublished - Dec 18 2017

Funding

None

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • anticoagulation
  • CHA2DS2VASc score
  • guideline
  • HAS-BLED score
  • nonvalvular atrial fibrillation
  • pharmacotherapy
  • stroke
  • Anticoagulation

Disciplines

  • Medicine and Health Sciences
  • Pharmacy and Pharmaceutical Sciences

Fingerprint

Dive into the research topics of 'Oral Anticoagulation Therapy upon Discharge in Hospitalized Patients with Nonvalvular Atrial Fibrillation: A Retrospective Cohort Study'. Together they form a unique fingerprint.

Cite this